Vanguri, Rami S.
Luo, Jia https://orcid.org/0000-0003-3606-827X
Aukerman, Andrew T. https://orcid.org/0000-0003-1944-769X
Egger, Jacklynn V.
Fong, Christopher J.
Horvat, Natally
Pagano, Andrew
Araujo-Filho, Jose de Arimateia Batista
Geneslaw, Luke
Rizvi, Hira
Sosa, Ramon
Boehm, Kevin M. https://orcid.org/0000-0003-2426-5436
Yang, Soo-Ryum
Bodd, Francis M.
Ventura, Katia
Hollmann, Travis J. https://orcid.org/0000-0003-1599-0433
Ginsberg, Michelle S.
Gao, Jianjiong
,
Vanguri, Rami
Hellmann, Matthew D.
Sauter, Jennifer L. https://orcid.org/0000-0001-6987-2294
Shah, Sohrab P. https://orcid.org/0000-0001-6402-523X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F30CA257414)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
Cycle for Survival
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007739)
Grayer Fellowship (MSKCC), Cycle for Survival
Susan G. Komen Scholars Program, Cycle for Survival
Article History
Received: 6 January 2022
Accepted: 29 June 2022
First Online: 29 August 2022
Competing interests
: J.L. has received honoraria from Targeted Oncology and Physicians’ Education Resource. M.D.H. as of November 2021, is an employee of AstraZeneca; has grants from BMS; and personal fees from Achilles; Adagene; Adicet; Arcus; AstraZeneca; Blueprint; BMS; DaVolterra; Eli Lilly; Genentech/Roche; Genzyme/Sanofi; Janssen; Immunai; Instil Bio; Mana Therapeutics; Merck; Mirati; Natera; Pact Pharma; Shattuck Labs; and Regeneron; as well as equity options from Factorial, Immunai, Shattuck Labs and Arcus. A patent filed by MSK related to the use of TMB to predict response to immunotherapy (PCT/US2015/062208) is pending and licensed by PGDx. T.J.H. receives funding from Bristol Myers Squibb and Calico labs. M.S.G. is a consultant for Ultimate Opinions in Medicine. J.L.S. reports stock ownership in Pfizer, Thermo Fisher Scientific, Merck & Co. and Chemed Corp. S.P.S. is a shareholder and consultant for Imagia Canexia Health. The remaining authors declare no competing interests.